NUWE Nuwellis, Inc.

BEARISH Impact: 7/10 S-1/A
Horizon immediate Filed May 29, 2026 Processed 14d 15h ago SEC 0001140361-26-023354
IPO registration amendment
Latest settled — T+5d
NUWE ▼ -75.71% at T+5d
SHORT call ✓ call won +75.71% · α vs SPY +72.96% · entry $0.7000 → $0.1700
Next anchor: T+20d in 16d
Currently $0.1400 · +80.00% from $0.7000 entry (call sign-flipped)
Entry anchored
May 29, 2026
via day open
T+1d
-15.71%
call +15.71% · α +15.86%
$0.5900
settled 12d ago
T+5d
-75.71%
call +75.71% · α +72.96%
$0.1700
settled 8d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Executive Summary

Nuwellis, Inc. filed Amendment No. 1 to its S-1 registration statement for a best-efforts standby equity offering of up to 6,578,948 shares of common stock (or pre-funded warrants in lieu thereof), together with Series C and Series D common warrants, at an assumed combined price of $0.76 per share and accompanying warrants. The offering has no minimum and terminates June 30, 2026; net proceeds are estimated at ~$4.4M if fully subscribed. The company has a $2M market cap, a history of operating losses (net loss of $17.5M in FY2025, accumulated deficit of $316.3M), and only enough cash to fund operations through Q2 2026, making this a dilutive emergency capital raise.

Actionable Insight

This is a dilutive emergency capital raise with no minimum, meaning the company may raise far less than needed. Monitor the closing date and actual proceeds raised — if less than ~$2M, cash runway concerns intensify. The stock has historically declined ~20% on average at T+20 after similar filings. Watch for any Nasdaq delisting risk if market value falls below proposed $5M threshold.

Key Facts

  • Offering of up to 6,578,948 shares of common stock (or pre-funded warrants) plus Series C warrants (3x) and Series D warrants (1x) at $0.76/share combined price
  • No minimum offering amount; terminates June 30, 2026
  • Estimated net proceeds of ~$4.4M if fully sold; only ~$950K if 25% sold
  • Cash and cash equivalents of $2.083M as of March 31, 2026; cash runway only through Q2 2026
  • Net loss of $17.5M for FY2025; accumulated deficit of $316.3M
  • Two material weaknesses in internal controls over financial reporting
  • Nasdaq bid price deficiency notice received June 2025; regained compliance via reverse stock split
  • Market cap of $2M; 0% analyst bullishness (0 buy, 3 hold, 3 sell/strong sell)
  • Series D warrants have zero-cash exercise — no additional proceeds expected from them
  • Common warrants require stockholder approval to become exercisable; if not obtained, warrants have no value

Financial Impact

Up to ~$4.4M net proceeds at full subscription; dilution of ~250% of current shares outstanding (2.64M to 9.21M shares post-offering)

dilutioncashworking capital

Risk Factors

  • Offering may raise significantly less than $4.4M due to no minimum; cash runway remains critical
  • Massive dilution: shares outstanding would increase ~250% from 2.64M to 9.21M
  • Common warrants require stockholder approval to be exercisable; if not obtained, warrants have no value
  • Nasdaq delisting risk if market value falls below proposed $5M threshold or bid price falls below $1.00 again
  • Going concern risk if additional capital not raised beyond this offering

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001140361-26-023354
Document: ny20073226x2_ex10-66.htm0001140361-26-023354
Document: ny20073226x2_ex4-4.htm0001140361-26-023354
14 reports for NUWE
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+1▲ +60.47%Jun 4, 2026
Filters
Rows
Reports for NUWE — sortable, filterable
Type Now
Jun 10, 2026
2d ago
8-K
BEARISH ★ 7/10
$0.1440 awaiting T+1awaiting T+1$0.1400 (+2.78%)
Jun 10, 2026
3d ago
Press Release
NEUTRAL ★ 4/10
$0.1440 awaiting T+1awaiting T+1$0.1400 (−2.78%)
Jun 9, 2026
4d ago
Press Release
BEARISH ★ 7/10
$0.1458 awaiting T+1awaiting T+1$0.1400 (+3.98%)
Jun 8, 2026
4d ago
424B4
BEARISH ★ 7/10
$0.1350 awaiting T+1awaiting T+1$0.1400 (−3.70%)
Jun 5, 2026
8d ago
Press Release
BEARISH ★ 8/10
$0.3007 awaiting T+1awaiting T+1$0.1400 (+53.44%)
Jun 4, 2026
8d ago
S-1/A
BEARISH ★ 7/10
$0.4300 $0.1700▲ +60.47%▲ +57.87%$0.1400 (+67.44%)
May 29, 2026
14d ago
S-1/A
BEARISH ★ 7/10
$0.7000 $0.5900▲ +15.71%▲ +15.86%$0.1400 (+80.00%)
May 22, 2026
21d ago
S-1
BEARISH ★ 7/10
$0.9100 $0.7600▲ +16.48%▲ +16.50%$0.1400 (+84.62%)
May 12, 2026
4w ago
Press Release
BEARISH ★ 7/10
$1.03 $1.03· 0.00%▲ +0.58%$0.1400 (+86.41%)
May 5, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$1.11 $1.09▼ −1.80%▼ −3.19%$0.1400 (−87.39%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (48h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access